BioCentury
ARTICLE | Company News

City of Hope, Fortress Biotech deal

May 11, 2015 7:00 AM UTC

City of Hope granted Fortress’ newly formed DiaVax Biosciences subsidiary exclusive, worldwide rights to develop and commercialize Triplex and PepVax -- two T cell immunotherapeutic peptide vaccines. Fortress also has an option to license exclusive, worldwide rights to develop and commercialize Pentamer. Coronado Biosciences Inc. changed its name to Fortress last month. ...